The G20 Global Health and Development Partnership is an advocacy organisation that aims to ensure that G20 countries are coordinating their health innovation strategy to tackle the growing burden of communicable and non-communicable diseases globally. The Partnership emerged on an informal basis initially functioning as an informal coalition of like-minded organisations. The Partnership emerged over several months of consultation and policy dialogue that included a lynchpin “G20 Global Health Innovation” roundtable in Berlin on April 28th, 2017. The event brought together a wider eclectic group of experts representing a broad set of international partnerships, with discussions culminating in a Rapporteur’s Report as well as a Call to Action signed by over a hundred individuals and organisations.
Following broad interest to build on the initiative, Sovereign Sustainability and Development (SSD) was created in late 2017 to act as the convener and secretariat of the Partnership. In consultation with a number of key stakeholders and confirmation from the Government of Argentina that health would remain a focus of the G20 under its Presidency, a Working Session was scheduled in the UK Houses of Parliament in December 2017 in order to collectively plot a course for the Partnership.
After another roundtable in May 2018 on “Health 20: Policies for Innovation & Irreversible Progress”, in the side-lines of the World Health Assembly (WHA) in Geneva, the G20 Health & Development Partnership has jointly drafted several recommendations in a Report in which the Partnership called upon the G20 Leaders to recognise the H20 as an official engagement group within the G20 and urged the G20 heads of government, health and finance ministers to incentivise innovation in health research and development and delivery. The Partnership also offered to develop a Report on best practices and blended and innovative forms of financing mechanisms, which will be presented to G20 Governments, Finance Ministers and Health Ministers during the Japanese G20 Presidency. Over the course of three years of building this initiative, the Partnership has broadcasted the messages to the highest political levels by engaging with policy-makers and the media to echo the common messages of the partners.
With the support of 21 leading global organisations, representing more than 1000 collaborators, the Partnership articulated the “Healthy Nations Sustainable Economies: How Innovation Can Better Ensure Health For All” Report. This report has been prepared for the G20 troika of Argentina, Japan and Saudi Arabia by including Germany in its focus based on its successful presidency championing health in 2017. The case studies in this report convincingly exemplify that through coordinated, innovative and sustained investment and cross-sectoral partnership models, further significant progress can be made within the timeframe of the United Nations Sustainable Development Goals.
As the G20 continue its focus on areas such as health emergencies, antimicrobial resistance (AMR), health systems strengthening and universal health coverage, the Partnership will seek to add value and support these areas of prioritisation and drive political support. The Partnership aims to align with the WHO’s 13th General Programme of Work (GPW13) by maintaining a focus on the broader innovation ecosystem. In 2019, the Partnership will organise a series of events including the launch of this report in the UK and a Health20 event in Tokyo that coincides with the G20 summit and the Joint Health- and Finance Ministers’ Meeting focusing on global health innovation and innovative financing for health. The Partnership will explore further potential avenues for advocating our agenda in national and international fora in and beyond the G20.